SNWV.png
SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)
April 10, 2024 08:30 ET | SANUWAVE Health, Inc.
SANUWAVE is pleased to announce preliminary revenues of $5.7 million to $5.9 million for the first quarter ended March 31, 2024. This represents the highest Q1 revenues in company history. Q1 2024...
SNWV.png
SANUWAVE Announces Record Q4 and FY2023 Revenue
March 22, 2024 06:00 ET | SANUWAVE Health, Inc.
Q4 2023 revenues were a record $7.0 million, up 27% from Q4 2022 FY 2023 revenues were a record $20.4 million, up 22% from FY2022 Operating income was $1 million for Q4 2023 compared to an operating...
SNWV.png
SANUWAVE Will Host a Conference Call on March 22, 2024 at 8:30 AM (ET) to Present the Q4 and FY2023 Financial Results
March 20, 2024 07:00 ET | SANUWAVE Health, Inc.
EDEN PRAIRIE, MN, March 20, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the "Company" or "Sanuwave”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound...
SNWV.png
SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of Stockholders
February 22, 2024 17:00 ET | SANUWAVE Health, Inc.
At a special meeting of stockholders on February 21, 2024, SANUWAVE stockholders approved the business combination with SEP Acquisition Corp. by a vote of 798,379,869 “for” and 5,221,765 “against”...
SNWV.png
SANUWAVE Announces Q3 2023 Financial Results
November 10, 2023 05:00 ET | SANUWAVE Health, Inc.
EDEN PRAIRIE, MN,, Nov. 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound...
SNWV.png
SANUWAVE Announces Q2 2023 Financial Results
August 11, 2023 06:00 ET | SANUWAVE Health, Inc.
EDEN PRAIRIE, MN, Aug. 11, 2023 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today...
SNWV.png
SANUWAVE Will Host a Live Conference Call on August 11, 2023 at 8:30 AM (EDT) to Present Its Q2 2023 Financial Results
August 09, 2023 17:22 ET | SANUWAVE Health, Inc.
EDEN PRAIRIE, MN, Aug. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live...
SNWV.png
SANUWAVE Signs Distribution Agreement With Pacific Medical, Inc.
August 01, 2023 07:30 ET | SANUWAVE Health, Inc.
Pacific Medical to bring its sales force of over 215 dedicated representatives covering seven western states to the SANUWAVE UltraMist line of directed energy wound care products. Long-term...
SNWV.png
SANUWAVE Health, Inc. Appoints Morgan Frank as Chief Executive Officer
May 24, 2023 09:00 ET | SANUWAVE Health, Inc.
Frank Brings 29 Years of Experience in Life Sciences, Technology, and Capital Markets Kevin Richardson to Remain at SANUWAVE as Chief Strategic Officer and as a Member of the Board of Directors ...
SNWV.png
SANUWAVE Announces Q1 2023 Financial Results
May 12, 2023 07:30 ET | SANUWAVE Health, Inc.
EDEN PRAIRIE, MN, May 12, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced 1st...